Dave A. Ghatt

Array ( [id] => 4283049 [patent_doc_number] => 06250469 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Formulations for protection of peg-interferon alpha conjugates' [patent_app_type] => 1 [patent_app_number] => 9/703581 [patent_app_country] => US [patent_app_date] => 2000-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3287 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/250/06250469.pdf [firstpage_image] =>[orig_patent_app_number] => 703581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4287992 [patent_doc_number] => 06268337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Methods for treating vascular disorders using activated protein C' [patent_app_type] => 1 [patent_app_number] => 9/465076 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5060 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268337.pdf [firstpage_image] =>[orig_patent_app_number] => 465076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533720 [patent_doc_number] => 06410694 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Method for solubilization and naturation of somatotropins' [patent_app_type] => B1 [patent_app_number] => 09/461784 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4531 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410694.pdf [firstpage_image] =>[orig_patent_app_number] => 09461784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4322634 [patent_doc_number] => 06331520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Pharmaceutical compositions of peptides having low solubility in physiological medium' [patent_app_type] => 1 [patent_app_number] => 9/451013 [patent_app_country] => US [patent_app_date] => 1999-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7789 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331520.pdf [firstpage_image] =>[orig_patent_app_number] => 451013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4083909 [patent_doc_number] => 06054555 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Process for the preparation of immobilized and activity-stabilized complexes of LHRH antagonists' [patent_app_type] => 1 [patent_app_number] => 9/422990 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1787 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054555.pdf [firstpage_image] =>[orig_patent_app_number] => 422990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260193 [patent_doc_number] => 06204247 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Chemical modification of proteins to improve biocompatibility and bioactivity' [patent_app_type] => 1 [patent_app_number] => 9/422396 [patent_app_country] => US [patent_app_date] => 1999-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 6382 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204247.pdf [firstpage_image] =>[orig_patent_app_number] => 422396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288102 [patent_doc_number] => 06268344 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Methods for treating hypercoagulable states or acquired protein C deficiency' [patent_app_type] => 1 [patent_app_number] => 9/415761 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7667 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268344.pdf [firstpage_image] =>[orig_patent_app_number] => 415761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157561 [patent_doc_number] => 06156734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Methods for treating hypercoagulable states or acquired protein C deficiency' [patent_app_type] => 1 [patent_app_number] => 9/415876 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7675 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156734.pdf [firstpage_image] =>[orig_patent_app_number] => 415876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1523919 [patent_doc_number] => 06352974 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Oral calcitonin pharmaceutical compositions and methods of making the same' [patent_app_type] => B1 [patent_app_number] => 09/297795 [patent_app_country] => US [patent_app_date] => 1999-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6601 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352974.pdf [firstpage_image] =>[orig_patent_app_number] => 09297795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4319975 [patent_doc_number] => 06248717 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Tartrate salt of a substituted dipeptide as growth hormone secretagogue' [patent_app_type] => 1 [patent_app_number] => 9/380886 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11303 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248717.pdf [firstpage_image] =>[orig_patent_app_number] => 380886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356019 [patent_doc_number] => 06200954 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Small peptides having potent anti-angiogenic activity' [patent_app_type] => 1 [patent_app_number] => 9/385442 [patent_app_country] => US [patent_app_date] => 1999-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 3678 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200954.pdf [firstpage_image] =>[orig_patent_app_number] => 385442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304236 [patent_doc_number] => 06187750 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Method of hormone treatment for patients with symptoms consistent with multiple sclerosis' [patent_app_type] => 1 [patent_app_number] => 9/385133 [patent_app_country] => US [patent_app_date] => 1999-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3814 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187750.pdf [firstpage_image] =>[orig_patent_app_number] => 385133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4398559 [patent_doc_number] => 06297354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Pentapeptide LHRH antagonists' [patent_app_type] => 1 [patent_app_number] => 9/373180 [patent_app_country] => US [patent_app_date] => 1999-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9899 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297354.pdf [firstpage_image] =>[orig_patent_app_number] => 373180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949272 [patent_doc_number] => 05998589 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Method of purifying human factor VIII' [patent_app_type] => 1 [patent_app_number] => 9/350605 [patent_app_country] => US [patent_app_date] => 1999-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 3371 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998589.pdf [firstpage_image] =>[orig_patent_app_number] => 350605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294155 [patent_doc_number] => 06235876 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Liquid phase process for the preparation of GNRH peptides' [patent_app_type] => 1 [patent_app_number] => 9/350231 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11491 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235876.pdf [firstpage_image] =>[orig_patent_app_number] => 350231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185042 [patent_doc_number] => 06159940 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Method for modulating hemopoiesis' [patent_app_type] => 1 [patent_app_number] => 9/340029 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 14670 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159940.pdf [firstpage_image] =>[orig_patent_app_number] => 340029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360858 [patent_doc_number] => 06255344 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Histidine derivatives, preparation, process, and their use as free antiradical agents' [patent_app_type] => 1 [patent_app_number] => 9/319170 [patent_app_country] => US [patent_app_date] => 1999-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5896 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255344.pdf [firstpage_image] =>[orig_patent_app_number] => 319170 [rel_patent_id] =>[rel_patent_doc_number] =>)